Recombine, Inc.

Industry

  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
See more in Biomedtracker

Latest on Recombine, Inc.

In Vivo

Device/Diagnostics Quarterly Deal Statistics, Q2 2016

 
• By Amanda Micklus and Maureen Riordan

Device Transactions The device industry pulled in $1.5 billion in financing during the second quarter of 2016, a 15% drop from Q1's $1.8 billion. Once again, debt offerings played a big role, represen

In Vivo

Deals In Depth: May 2016

 
• By Amanda Micklus

Open Media